WHO push to tackle rampant rise of diabetes
The World Health Organization on Wednesday turned the spotlight on the insulin market—and its domination by three Big Pharma giants—in a fresh bid to tackle the rapid rise of diabetes.
Apr 14, 2021
0
3
The World Health Organization on Wednesday turned the spotlight on the insulin market—and its domination by three Big Pharma giants—in a fresh bid to tackle the rapid rise of diabetes.
Apr 14, 2021
0
3
The European Commission said Wednesday it had forced South African drugs giant Aspen to slash prices on six cancer drugs after finding it abused its market dominance to hike charges.
Feb 10, 2021
0
0
The net cost of prescription drugs—meaning sticker price minus manufacturer discounts—rose over three times faster than the rate of inflation over the course of a decade, according to a study published today in JAMA. ...
Mar 3, 2020
1
822
U.S. drug companies have started the new year by raising the prices of hundreds of medications.
Jan 7, 2020
0
2
U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price ...
Nov 26, 2019
0
3
New research findings presented at the 2019 ACR/ARP Annual Meeting found that annual spending on biologic DMARDS (biologics) by U.S. public programs and beneficiaries nearly doubled from 2012 to 2016. The study showed post-market ...
Nov 10, 2019
0
1
Greater brand-brand competition alone will likely not lower list prices of brand-name drugs in the US, according to a study published July 30 in the open-access journal PLOS Medicine by Ameet Sarpatwari of Brigham and Women's ...
Jul 30, 2019
0
4
Canada's new 2019 food guide uses nutritional science to define what a wholesome diet looks like. This is a great improvement over previous versions, but it raises important questions about the accessibility of healthy food ...
Jun 6, 2019
1
18
Israeli pharmaceutical giant Teva vowed Saturday to defend itself after being accused of orchestrating price-fixing among drugmakers in a US antitrust lawsuit.
May 11, 2019
0
0
(HealthDay)—Some Americans with type 1 diabetes have cut back on their insulin usage as the cost of the drug nearly doubled over a five-year period.
Jan 24, 2019
0
0